- Home
- CTXR vs BATL Comparison
CTXR vs BATL Comparison
Compare CTXR & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTXR | BATL |
|---|---|---|
| Founded | 2007 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 17.9M |
| IPO Year | 2010 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CTXR | BATL |
|---|---|---|
| Price | $0.84 | $18.76 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 585.2K | ★ 15.6M |
| Earning Date | 06-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.38 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $193,893,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $147.57 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $1.00 |
| 52 Week High | $2.38 | $29.70 |
Technical Indicators
Market Signals| Indicator | CTXR | BATL |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 65.92 |
| Support Level | $0.66 | $1.23 |
| Resistance Level | $0.97 | N/A |
| Average True Range (ATR) | 0.07 | 4.02 |
| MACD | 0.02 | 1.67 |
| Stochastic Oscillator | 58.09 | 59.94 |
Price Performance
Historical ComparisonAbout CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.